These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6336396)

  • 1. Haemostasis parameters behaviour during haemodialysis without anticoagulants.
    Casati S; Moia M; Graziani G; Cantaluppi A; Mannucci PM; Ponticelli C
    Life Support Syst; 1983; 1 Suppl 1():144-7. PubMed ID: 6336396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of low molecular weight heparin anticoagulation during haemodialysis with a Sonoclot Analyzer.
    Schött U; Nilsson LG; Broman M; Engström M
    Perfusion; 2010 Jul; 25(4):191-6. PubMed ID: 20530518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation in renal failure.
    Hassaballa A; Fahmy T; el-Ghoneimy E; el-Ayadi A; el-Badry A
    J Egypt Med Assoc; 1975; 58(3-4):105-21. PubMed ID: 1223190
    [No Abstract]   [Full Text] [Related]  

  • 5. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR
    Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood 17-hydroxycorticosteroids and their elimination during hemodialysis in acute and chronic renal insufficiency].
    Timokhov VS; Ryzhenko VM; Shaposhnikova VV
    Ter Arkh; 1976; 48(10):99-104. PubMed ID: 1024286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodialysis without risk of hemorrhage. Introduction of an APTT bedside method for exact heparin monitoring--a review].
    Vogel GE
    Fortschr Med; 1977 Oct; 95(40):2437-44. PubMed ID: 924326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of dialysis on plasma cortisol concentration in patients with renal failure].
    Szewczyk Z; Silber D; Skiba W; Checińska E; Szepietowski T; Kopeć W
    Pol Tyg Lek; 1975 Dec; 30(49):2037-40. PubMed ID: 1197088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [False positive digoxin levels in the blood of patients with kidney failure before and after hemodialysis].
    Ivanović D; Duraković Z; Gjurasin M; Gasparović V; Plavsić F
    Lijec Vjesn; 1986 Jun; 108(6):245-7. PubMed ID: 3724350
    [No Abstract]   [Full Text] [Related]  

  • 13. Amino nitrogen loss during haemodialysis, its dietary significance and replacement.
    Young GA; Parsons FM
    Clin Sci; 1966 Oct; 31(2):299-307. PubMed ID: 5955726
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum deoxyribosides in renal failure].
    Tabernero Romo JM; Pérez Sandoval D; Vicente Rodríguez P; Macias NUNEZ JF; de Castro del Pozo S
    Rev Clin Esp; 1976 Feb; 140(4):327-32. PubMed ID: 1265316
    [No Abstract]   [Full Text] [Related]  

  • 15. [Control of heparinization in the hemodialysis for acute kidney failure].
    Vogel GE; Goldmann FL; Jelen S; Tempel G
    Med Welt; 1977 May; 28(19):899-902. PubMed ID: 881979
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes of the lactate content of the arterial blood of patients with renal insufficiency].
    Barousse AP; De Bercovich C; Grassino A; Firmat J
    Medicina (B Aires); 1967; 27(1):20-6. PubMed ID: 5594901
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of regional heparinization in hemodialysis operations ("artificial kidney")].
    Agranenko VA; Kaveshnikova BF
    Khirurgiia (Mosk); 1965 Sep; 41(9):84-90. PubMed ID: 5879002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of low-molecular weight heparin during hemodialysis].
    Kalinowski M; Pawlak K; Myśliwiec M; Popławski A
    Pol Merkur Lekarski; 1997 Jan; 2(9):208-10. PubMed ID: 10907031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of low molecular weight heparin as an anti-coagulant for hemodialysis].
    Akizawa T; Kanamori N; Koshikawa S
    Rinsho Byori; 1990 Jul; Suppl 86():171-6. PubMed ID: 2172593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.